help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, N.
Right arrow Articles by Takagi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, N.
Right arrow Articles by Takagi, Y.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 2 697-702
Copyright © 1998 by The Endocrine Society


Original Studies

Localized Aberrant Expression of Cytochrome P450 Aromatase in Primary and Metastatic Malignant Tumors of Human Liver1

Nobuhiro Harada, Hiroyoshi Ota, Noriko Yoshimura, Tsutomu Katsuyama and Yasuyuki Takagi

Division of Molecular Genetics (N.H., N.Y., Y.T.), Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470, Japan; and the Department of Laboratory Medicine (H.O., T.K.), Shinshu University School of Medicine, Matsumoto, Nagano 390, Japan

Address all correspondence and requests for reprints to: Nobuhiro Harada, Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Toyoake, Aichi 470–11, Japan. nharada@fujita-hu.ac.jp.

The present study was designed to demonstrate localized aberrant expression of aromatase in primary and metastatic malignant liver tumors. Immunocytochemistry revealed the presence of locally increased aromatase protein in regions around tumors in all specimens from seven primary and seven metastatic liver tumors. This observation was further confirmed by Western blotting analysis and assay of aromatase activity in tumorous, proximal, and distal regions. Western blots showed most intensely immunoreactive bands at the position corresponding to aromatase in proximal tissues where aromatase activities also were higher (2.75 ± 1.59 pmol/mg·h) than in tumors (0.137 ± 0.115 pmol/mg·h) and distal tissues (1.90 ± 1.47 pmol/mg·h), in spite of a gradient decline of NADPH-cytochrome P-450 reductase activity from the distal regions to the tumors. RT-PCR analysis indicated that the aberrant increase in aromatase protein and enzyme activity in the regions proximal to tumors is caused by locally elevated aromatase messenger RNA.




This article has been cited by other articles:


Home page
Cancer Res.Home page
L. A. M. Castagnetta, B. Agostara, G. Montalto, L. Polito, I. Campisi, A. Saetta, T. Itoh, B. Yu, S. Chen, and G. Carruba
Local Estrogen Formation by Nontumoral, Cirrhotic, and Malignant Human Liver Tissues and Cells
Cancer Res., August 15, 2003; 63(16): 5041 - 5045.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Sumitani, M. Shozu, T. Segawa, K. Murakami, H.-J. Yang, K. Shimada, and M. Inoue
In Situ Estrogen Synthesized by Aromatase P450 in Uterine Leiomyoma Cells Promotes Cell Growth Probably Via an Autocrine/Intracrine Mechanism
Endocrinology, October 1, 2000; 141(10): 3852 - 3861.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society